A new non-prescription Reproductive Support Dietary Supplement, Pregnitude™, which contains myo-inositol (2 g), plus folic acid (200 mcg), is now available for women who are having difficulty conceiving, Everett Laboratories announced today. In clinical studies, Pregnitude has been shown to help support ovulation function and menstrual cycle regularity as well as support the quality of a woman's eggs.
"Everett Labs is proud to make this new, important contribution to women's health. With Pregnitude, we're thrilled to provide a new option to support women who are having difficulty conceiving. We are confident that obstetricians and gynecologists around the country will find this a valuable alternative for women to support the ovulation frequency, regularity and quality of eggs," said Lucas Sigman, Chief Executive Officer, Everett Laboratories, Inc.
Myo-inositol is a naturally occurring substance produced in the human body that belongs to the vitamin B complex group and is found naturally in many foods such as fruits, cereals with high bran content, nuts and beans. Both myo-inositol and folic acid are considered to be important nutrients for women who are trying to become pregnant.
Approximately 6.1 million women in the United States have difficulty getting pregnant, according to the Centers for Disease Control and Prevention (CDC).
"There is a tremendous need for support of couples having difficulty conceiving. They're often left frustrated and anxious, and the stress can compound the problem. Pregnitude can help support ovulation function, menstrual cycle regularity, and quality of eggs during this difficult time," said Scott Eder, M.D., Medical Director, Everett Laboratories and a board-certified obstetrician and gynecologist who practices in Lawrenceville, NJ.
Pregnitude is a powder formulation that is mixed with water and taken twice a day, in the morning and evening. It is available without a prescription at most major retail pharmacies and can be found behind the pharmacy counter. Consumers can also order Pregnitude online, at www.pregnitude.com.
Clinical Trials with Myo-inositol in Combination with Folic Acid
Controlled clinical studies have demonstrated that supplementation with myo-inositol has a beneficial effect on ovulatory function, improving ovulation frequency, promoting menstrual cycle regularity and improving the quality of oocytes, or immature eggs.
"The results of the clinical trials with myo-inositol supplementation are particularly encouraging in supporting ovarian function. We are thrilled to provide another tool to support women wishing to become pregnant," said Dr. Eder.
Side effects and Who Should Not Use Pregnitude
Pregnitude is generally well tolerated. Women may experience gastrointestinal effects such as nausea and diarrhea when taken at high doses. Pregnitude should not be taken by anyone with a known hypersensitivity to either myo-inositol or folic acid. Folic acid should not be taken by anyone with untreated or uncomplicated pernicious anemia and those with anaphylactic sensitivity to folic acid. In addition, high doses of myo-inositol may have additive effects when taken concurrently with selective serotonin reuptake inhibitor (SSRI) and selective serotonin norepinephrine reuptake inhibitor (SNRI) antidepressant medications. Women who take these medications should talk to their doctor before using Pregnitude.
Everett Laboratories, Inc.